• 제목/요약/키워드: E. coli inhibition

검색결과 417건 처리시간 0.023초

Expression of a Glutathione Reductase from Brassica rapa subsp. pekinensis Enhanced Cellular Redox Homeostasis by Modulating Antioxidant Proteins in Escherichia coli

  • Kim, Il-Sup;Shin, Sun-Young;Kim, Young-Saeng;Kim, Hyun-Young;Yoon, Ho-Sung
    • Molecules and Cells
    • /
    • 제28권5호
    • /
    • pp.479-487
    • /
    • 2009
  • Glutathione reductase (GR) is an enzyme that recycles a key cellular antioxidant molecule glutathione (GSH) from its oxidized form (GSSG) thus maintaining cellular redox homeostasis. A recombinant plasmid to overexpress a GR of Brassica rapa subsp. pekinensis (BrGR) in E. coli BL21 (DE3) was constructed using an expression vector pKM260. Expression of the introduced gene was confirmed by semi-quantitative RT-PCR, immunoblotting and enzyme assays. Purification of the BrGR protein was performed by IMAC method and indicated that the BrGR was a dimmer. The BrGR required NADPH as a cofactor and specific activity was approximately 458 U. The BrGR-expressing E. coli cells showed increased GR activity and tolerance to $H_2O_2$, menadione, and heavy metal ($CdCl_2$, $ZnCl_2$ and $AlCl_2$)-mediated growth inhibition. The ectopic expression of BrGR provoked the co-regulation of a variety of antioxidant enzymes including catalase, superoxide dismutase, glutathione peroxidase, and glucose-6-phosphate dehydrogenase. Consequently, the transformed cells showed decreased hydroperoxide levels when exposed to stressful conditions. A proteomic analysis demonstrated the higher level of induction of proteins involved in glycolysis, detoxification/oxidative stress response, protein folding, transport/binding proteins, cell envelope/porins, and protein translation and modification when exposed to $H_2O_2$ stress. Taken together, these results indicate that the plant GR protein is functional in a cooperative way in the E. coli system to protect cells against oxidative stress.

향신료 첨가에 의한 닭고기 분쇄육에서의 미생물 증식 억제 효과 (Effects of Spice Addition on the Inhibition of Bacterial Growth in Ground Chicken Meat)

  • 정세윤;김용석
    • 한국식품위생안전성학회지
    • /
    • 제38권1호
    • /
    • pp.19-25
    • /
    • 2023
  • 비가열 닭고기 분쇄육의 제조 시 향신료의 첨가에 의한 세균의 증식 억제 효과에 대하여 연구하였다. 닭가슴살 분쇄육의 일반성분은 수분 72.98±0.15%, 조단백질 23.37±0.46%, 조지방 1.00±0.03%, 조회분 1.90±0.03%였다. 향신료 첨가에 의한 미생물 증식 억제 효과는 로즈마리 > 마늘 > 겨자 순이었으며, 첨가량이 증가할수록 억제 효과가 커졌다. 닭고기 분쇄육의 일반세균 및 대장균 증식 억제를 나타내는 향신료의 최적 첨가 농도는 로즈마리 2%, 마늘 4%, 겨자 1.2%였다. 일반세균 및 대장균에 대한 증식 억제 효과는 단독 및 혼합 첨가 시 저장기간 동안 기간별로 차이가 있었고, 저장 9일째 억제 효과는 MixA(97.4%) > 로즈마리(96.9%) > MixB(96.3%) > 마늘(53.7%) > 겨자(33.3%) 순이었다. 닭고기 분쇄육에 살균마늘과 비살균마늘을 첨가하여 비교했을 때 일반세균 수는 살균마늘 처리구가 비살균마늘 처리구에 비해 초기 2.6-3.0 log CFU/g, 9일째 2.4-3.2 log CFU/g 정도 낮았고, 저장기간이 경과할수록 그 수가 감소하였다. 비살균마늘 처리구는 대조구보다 높은 일반세균 수를 나타냈으며, 저장기간이 경과할수록 증가하는 경향을 나타냈다. 대장균 수의 경우 살균마늘 처리구가 비살균마늘 처리구에 비해 저장 0일째 0.4-1.0 log CFU/g, 9일째 0.5-1.5 log CFU/g 정도 낮았으며, 저장기간의 경과에 따른 변화는 일반세균 수와 비슷한 경향을 나타냈다. 결론적으로 로즈마리, 마늘, 겨자의 다양한 혼합적용에 의해 닭고기 분쇄육 제품의 미생물적 안전성이 향상되었다.

유전자 재조합 대장균을 사용한 Alpha-interferon의 생산과 분비: 제2부. 재조합 균주의 생장특성 (Extracellular Production of Alpha-Interferon by Recombinant Escherichia coli: Part II. The Growth Behavior of the Recombinant Cells)

  • 노갑수;최차용
    • KSBB Journal
    • /
    • 제5권3호
    • /
    • pp.195-200
    • /
    • 1990
  • 대장균의 lipoprotein promoter, lactose promotor 및 operator 와 lipoprotein의 signal sequence 를 가지는 vector에alpha-IFN 유전자가 cloning된 plasmid pIF-Ill-B를 여러종류의 대장균 숙주 세포에 형칠전환하여 alpha-IFN 의 생산성, 생장특성을 조사하였다. 또한 plasmid 자체와 cloning된 alpha-IFN 유전자의 발현유도가 세포생장에 미치는 영 향을 조사하였다.

  • PDF

벼 렉틴 유전자의 클로닝 및 대장균에서의 발현 (Molecular Cloning and Expression of Rice Lectin in Escherichia coli)

  • 홍성관;전상훈;김하형;공광훈
    • 약학회지
    • /
    • 제46권4호
    • /
    • pp.270-275
    • /
    • 2002
  • The lectin gene from rice was amplified by the polymerase chain reaction. The amplified DNA was inserted into the expression vector pET26b and expressed it as a fusion protein with polyhistidine sequences in Escherichia coli. The recombinant protein was produced by induction with 0.4 mM isopropyl-$\beta$-D-thiogalactopyranoside at 37$^{\circ}C$ and purified by an immobilized metal affinity chromatography. The recombinant protein was found to have lectin activity by the hemagglutination inhibition assay. The hemagglutination activity of the recombinant protein was optimal at pH 4.0-7.0 and was dependent on $Ca^{2+}$ and Mn$^{2+}$.2+/.

Effects of tktA, $aroF^{FBR}$and aroL Expression in the Tryptophan-Producing Escherichia coli

  • Kim, Tae-Hyun;Namgoong, Suk;Kwak, Joon-Hyeok;Lee, Se-Yong;Lee, Heung-Shick
    • Journal of Microbiology and Biotechnology
    • /
    • 제10권6호
    • /
    • pp.789-796
    • /
    • 2000
  • In order to analyze the effects of tktA, $aroF^{FBR}$, and aroL expression in a tryptophan-producing Escherichia coli, a series of plasmids carrying the genes were constructed. Introduction of tktA, $aroF^{FBR}$, and aroL into the E. coli strain resulted in approximately 10-20 fold increase in the activities of transketolase, the feedback inhibition-resistant 3-deoxy-D-arabinoheptulsonate-7-phosphate synthase, and shikimate kinase. Expression of $aroF^{FBR}$ in the aroB mutant strain of E. coli resulted in the accumulation of 10 mM of 3-deoxy-D-arabinoheptulsonate-7-phosphate (DAHP) in the medium. Simultaneous expression of tktA and $aroF^{FBR}$ in the strain further increased the amount of excreted DAHP to 20 mM. In contrast, the mutant strain which has no gene introduced accumulated 0.5 mM of DAHP. However, the expression of tktA and $aroF^{FBR}$ in a tryptophan-producing E. coli strain did not lead to the increased production of tryptophan, but instead, a significant amount of shikimate, which is an intermediate in the tryptophan biosynthetic pathway, was excreted to the growth medium. Despite the fact that additional expression of shikimate kinase in the strain could possibly remove 90% of excreted shikimate to 0.1 mM, the amount of tryptophan produced was still unchanged. Removing shikimate using a cloned aroL gene caused the excretion of glutamate, which suggests disturbed central carbon metabolism. However, when cultivated in a complex medium, the strain expressing tktA, $aroF^{FBR}$, and aroL produced more tryptophan than the parental strain. These data indicate that additional rate-limiting steps are present in the tryptophan biosynthetic pathway, and the carbon flow to the terminal pathway is strictly regulated. Expressing tktA in E. coli cells appeared to impose a great metabolic burden to the cells as evidenced by retarded cell growth in the defined medium. Recombinant E. coli strains harboring plasmids which carry the tktA gene showed a tendency to segregate their plasmids almost completely within 24h.

  • PDF

배지의 pH 조정에 의한 홍삼 추출물 첨가가 Lactobacillus SP., Escherichia coli와 Listeria monocytogenes의 생육에 미치는 영향 (Effect of Red Ginseng, Extract on Growth of Lactobacillus sp., Escherichia coli and Listeria monocytogenes in pH Controled Medium)

  • 배형철;이조윤;남명수
    • 한국축산식품학회지
    • /
    • 제25권2호
    • /
    • pp.257-264
    • /
    • 2005
  • 홍삼 추출물이 유산간균 3종(L. acidophilus, L. casei 및 L. salivarius ssp. salivarius)과 병원성 균으로서 E. coli 및 L. monocytogenes에 대한 성장 촉진과 억제 효과를 홍삼 추출물 0, 1, 2, 5와 $10\%$ 농도로 조사하였으며, 홍삼 추출물에 의한 pH 저하를 buffer제를 사용하여 조정하고 미생물의 성장을 대조구와 비교하여 조사하였다. 유산간균 3종의 경우 홍삼 추출물 $1\%$ 농도까지는 무처리구와 유사한 성장을 보였으나, $2\%$이상의 홍삼 추출물 첨가 시 농도가 높아질수록 유산균의 성장도 둔화되었다. E. coli의 경우 홍삼 추출물이 $1\%$부터 높아질수록 성장이 억제되었고, L. monocytogenes의 경우 $5\%$ 이상의 처리구에서 억제 효과가 있었다. Buffer제를 사용하여 pH를 조정하고 홍삼 추출물을 $10\%$ 첨가한 구와 pH를 조정하지 않은 구를 비교하여 보면 유산간균과 병원성 균의 성장이 두 구간에 모두 억제되므로 미생물의 억제 효과가 홍삼 추출물 중의 유기산에 의한 pH 저하가 원인이 아님을 알 수 있었으며, 이와 같은 미생물의 성장억제 효과는 홍삼 추출물 중 다른 유효성분에 의한 것으로 생각되어진다.

대장균 배양에서의 유기산 생성과 투석배양에 관한 연구 (A Study of Organic Acid Formation and Dialysis Culture in E. coli Fermentation)

  • 김인호
    • KSBB Journal
    • /
    • 제8권4호
    • /
    • pp.382-389
    • /
    • 1993
  • 초산이온이 대장균 성장을 저해하는 현상을 규명 하기 위해서 M9 배지, LB 배지를 사용해서 플라스 크, 발효조 배양을 수행하였다. 대장균의 초산 생성 은 높은 포도당 초기 농도, LB 배지와 같은 복합 배 지에서 활발하였고, 플라스크 배양과 같은 pH 조절 이 되지 않는 배양방법에셔는 초산의 생성에 따른 pH 감소에 따라 세포성장이 많이 저해되었다. 초산 을 외부에서 첨가하여 세포성장에 마치는 영향을 조 사하여 보았는데 LB 배지를 사용한 플라스크 배양 에서는 첨가된 초산의 농도가 2g/l 이상, M9 배지 를 사용한 플라스크 배양에서는 초산의 농도가 4g/l 이상, 그리고 M9 배지를 사용한 발효조 배양에 셔는 8g/l 이상에서 초산의 성장 저해효과가 나타 다. LB 한천 배지를 볕에 깐 LB 액체 배지의 플라스 크 배양을 수행하였다. LB 한천의 양이 증가함에 따라서 한천에서 포도당의 방출이 일어나 최종 대장 균 세포 O.D.가 증가하였다.

  • PDF

Expression in Escherichia coli of a Putative Human Acetohydroxyacid Synthase

  • Duggleby, Ronald G.;Kartikasari, Apriliana E.R.;Wunsch, Rebecca M.;Lee, Yu-Ting;Kil, Mee-Wha;Shin, Ju-Young;Chang, Soo-Ik
    • BMB Reports
    • /
    • 제33권3호
    • /
    • pp.195-201
    • /
    • 2000
  • A human gene has been reported that may encode the enzyme acetohydroxyacid synthase. Previously this enzyme was thought to be absent from animals although it is present in plants and many microorganisms. In plants, this enzyme is the target of a number of commercial herbicides and the use of these compounds may need to be reassessed if the human enzyme exists and proves to be susceptible to inhibition. Here we report the construction of several plasmid vectors containing the cDNA sequence for this protein, and their expression in Escherichia coli. High levels of expression were observed, but most of the protein proved to be insoluble. The small amounts of soluble protein contained little or no acetohydroxyacid synthase activity. Attempts to refold the insoluble protein were successful insofar as the protein became soluble. However, the refolded protein did not gain any acetohydroxyacid synthase activity. In vivo complementation tests of an E. coli mutant produced no evidence that the protein is active. Incorrect folding, or the lack of another subunit, may explain the data but we favor the interpretation that this gene does not encode an acetohydroxyacid synthase.

  • PDF

Antimicrobial Activity of Quinoline Derivatives Isolated from Ruta chalepensis Toward Human Intestinal Bacteria

  • CHO JANG-HEE;LEE CHI-HOON;LEE HOI-SEON
    • Journal of Microbiology and Biotechnology
    • /
    • 제15권3호
    • /
    • pp.646-651
    • /
    • 2005
  • The growth responses of Ruta chalepensis leaf-derived materials toward human intestinal bacteria were examined. The biologically active constituent of the R. chalepensis extract was characterized as quinoline-4-carboxaldehyde($C_{10}H_{7}NO$). The growth responses varied depending on the bacterial strain, chemicals, and dose tested. At 0.25 and 0.1 mg/disk, quinoline-4-carboxaldehyde strongly inhibited the growth of Clostridium perfringens and weakly inhibited the growth of Escherichia coli without any adverse effects on the growth of three lactic acid bacteria. Furthermore, at 0.05 and 0.025 mg/disk, this isolate showed moderate activity against C. perfringens. In comparison, chloramphenicol at as low as 0.01 mg/disk significantly inhibited the growth of all bacteria tested, and cinnamaldehyde at 0.25 mg/disk did not inhibit Bifidobacterium bifidum, B. longum, E. coli, and Lactobacillus acidophilus, with the exception of C. perfringens. The structure-activity relationship revealed that quinoline-3-carboxaldehyde had strong growth inhibition against C. perfringens, but quinoline, quinoline-3-carboxylic acid, and quinoline-4-carboxylic acid did not inhibit the growth of B. bifidum, B. longum, C. perfringens, E. coli, and L. acidophilus. These results indicate that the carboxyl aldehyde functional group of quinolines seems to be required for growth-inhibiting activity against C. perfringens, thus indicating at least one of the pharmacological actions of R. chalepensis leaf.

Co-Expression of a Chimeric Protease Inhibitor Secreted by a Tumor-Targeted Salmonella Protects Therapeutic Proteins from Proteolytic Degradation

  • Quintero, David;Carrafa, Jamie;Vincent, Lena;Kim, Hee Jong;Wohlschlegel, James;Bermudes, David
    • Journal of Microbiology and Biotechnology
    • /
    • 제28권12호
    • /
    • pp.2079-2094
    • /
    • 2018
  • Sunflower trypsin inhibitor (SFTI) is a 14-amino-acid bicyclic peptide that contains a single internal disulfide bond. We initially constructed chimeras of SFTI with N-terminal secretion signals from the Escherichia coli OmpA and Pseudomonas aeruginosa ToxA, but only detected small amounts of protease inhibition resulting from these constructs. A substantially higher degree of protease inhibition was detected from a C-terminal SFTI fusion with E. coli YebF, which radiated more than a centimeter from an individual colony of E. coli using a culture-based inhibitor assay. Inhibitory activity was further improved in YebF-SFTI fusions by the addition of a trypsin cleavage signal immediately upstream of SFTI, and resulted in production of a 14-amino-acid, disulfide-bonded SFTI free in the culture supernatant. To assess the potential of the secreted SFTI to protect the ability of a cytotoxic protein to kill tumor cells, we utilized a tumor-selective form of the Pseudomonas ToxA (OTG-PE38K) alone and expressed as a polycistronic construct with YebF-SFTI in the tumor-targeted Salmonella VNP20009. When we assessed the ability of toxin-containing culture supernatants to kill MDA-MB-468 breast cancer cells, the untreated OTG-PE38K was able to eliminate all detectable tumor cells, while pretreatment with trypsin resulted in the complete loss of anticancer cytotoxicity. However, when OTG-PE38K was co-expressed with YebF-SFTI, cytotoxicity was completely retained in the presence of trypsin. These data demonstrate SFTI chimeras are secreted in a functional form and that co-expression of protease inhibitors with therapeutic proteins by tumor-targeted bacteria has the potential to enhance the activity of therapeutic proteins by suppressing their degradation within a proteolytic environment.